FDA has approved the first and only science-based treatment for growing eyelashes. LATISSE was developed by Allergan, the company behind Botox.Latisse is a prescription treatment that has to be applied daily on a continued basis. As a result of regular continued use, the length, thickness and colour of eyelashes are visibly improved. Side effects of Latisse can include eye redness and itchiness. More serious but less common side-effects could be darkening of the eye iris or of the eyelid skin and, according to some reports, even permanent darkening of the whites of the eyes.
Latisse is based on a chemical called prostaglandin, which is used to treat glaucoma. It was the side effect observed in the patients treated for glucoma with prostaglandin that inspired developemtn of this eyelash enhancement treatment.
Latisse will be available early next year and a month supply is expected to cost you over a hundren dollars. Which makes it quite an expense over a year.
Sources:Telegraph.co.uk
Medical News Today
ABC News Report at video.yahoo.com
No comments:
Post a Comment